PRADA Trial: Prevention Of Cardiac Dysfunction During Adjuvant Breast Cancer Therapy: Long-term Follow-up Of A 2 X 2 Factorial, Randomized, Placebo-controlled, Double-blind Clinical Trial Of Candesartan And Metoprolol
Dr. Geeta Gulati, Dr. Siri Lagethon Heck and Prof. Torbjorn Omland presenting the new result from PRADA Trial.
Presenter:
Siri Lagethon Heck
Cardiology